J&J says won’t enforce AIDS drug patent in Africa

LONDON (Reuters) – Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson’s HIV/AIDS drug Prezista for sale in Africa and other poor countries. U.S. healthcare group J&J said on Thursday it would not enforce patents, provided generic firms made high-quality versions of the drug – known generically as darunavir – for sub-Saharan Africa and Least Developed Countries. Prezista is a relatively new drug used when patients develop resistance to older antiretrovirals. …
Sexual Health News Headlines – Yahoo! News